Pharmacoeconomic Analisys of Ixabepilone Monotherapy in Patients with Advanced or Metastatic Breast Cancer Resistant To Anthracyclines, Taxanes and Capecitabine
Abstract
Authors
A Kolbin A Mosikian A Kurylev Y Balykina M Proskurin